Advertisement
Advertisement
WST
West Pharmaceutical Services, Inc.
237.05
USDSponsored
-3.28
-1.36%
Mar 20, 15:59 UTC -4
Closed
After-Market
236.59
-0.46
-0.20%
WST Earnings Reports
Positive Surprise Ratio
WST beat 35 of 40 last estimates.
88%
Next Report
Date of Next Report
Apr 22, 2026
Estimate for Q1 26 (Revenue/ EPS)
$786.62M
/$1.69
Implied change from Q4 25 (Revenue/ EPS)
-2.28%
/-17.16%
Implied change from Q1 25 (Revenue/ EPS)
+12.70%
/+16.55%
West Pharmaceutical Services, Inc. earnings per share and revenue
On Feb 12, 2026, WST reported earnings of 2.04 USD per share (EPS) for Q4 25, beating the estimate of 1.85 USD, resulting in a 10.23% surprise. Revenue reached 805.00 million, compared to an expected 802.32 million, with a 0.33% difference. The market reacted with a -1.04% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 12 analysts forecast an EPS of 1.69 USD, with revenue projected to reach 786.62 million USD, implying an decrease of -17.16% EPS, and decrease of -2.28% in Revenue from the last quarter.
FAQ
What were West Pharmaceutical Services, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, West Pharmaceutical Services, Inc. reported EPS of $2.04, beating estimates by 10.23%, and revenue of $805.00M, 0.33% above expectations.
How did the market react to West Pharmaceutical Services, Inc.'s Q4 2025 earnings?
The stock price moved down -1.04%, changed from $246.16 before the earnings release to $243.61 the day after.
When is West Pharmaceutical Services, Inc. expected to report next?
The next earning report is scheduled for Apr 22, 2026.
What are the forecasts for West Pharmaceutical Services, Inc.'s next earnings report?
Based on 12
analysts, West Pharmaceutical Services, Inc. is expected to report EPS of $1.69 and revenue of $786.62M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement